Current Value
$2.651 Year Return
Current Value
$2.651 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AMC | 55.41% | $1.37B | -19.19% | 0.00% |
GME | 43.69% | $12.39B | +93.98% | 0.00% |
OSUR | 36.02% | $277.49M | -53.85% | 0.00% |
DEI | 33.48% | $2.88B | +26.69% | 4.36% |
SBH | 33.48% | $1.14B | -5.19% | 0.00% |
RGNX | 32.07% | $354.25M | -48.08% | 0.00% |
CLNE | 31.61% | $634.62M | -8.39% | 0.00% |
SKLZ | 31.56% | $108.64M | +26.09% | 0.00% |
CRSP | 30.58% | $3.44B | -33.91% | 0.00% |
MPW | 29.47% | $2.40B | +30.29% | 11.50% |
IRBT | 29.36% | $253.64M | -64.86% | 0.00% |
ARCT | 29.35% | $460.76M | -47.29% | 0.00% |
CWH | 29.06% | $1.39B | -6.42% | 2.13% |
BXP | 29.03% | $11.45B | +8.93% | 5.37% |
SLG | 28.54% | $4.69B | +53.92% | 4.55% |
MBC | 28.27% | $2.14B | +18.68% | 0.00% |
EDIT | 28.17% | $102.36M | -84.82% | 0.00% |
CHPT | 27.98% | $486.58M | -33.33% | 0.00% |
TPR | 27.85% | $16.23B | +94.33% | 1.99% |
OMER | 27.68% | $531.98M | +137.21% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SRG | -24.87% | $220.01M | -58.97% | 0.00% |
TEM | -15.67% | $5.47B | 0.00% | 0.00% |
EW | -14.66% | $41.20B | -6.15% | 0.00% |
BAH | -12.74% | $17.42B | +6.76% | 1.49% |
FARM | -10.76% | $35.66M | -47.65% | 0.00% |
RSG | -10.35% | $66.36B | +26.33% | 1.05% |
FF | -10.28% | $235.88M | +38.89% | 4.47% |
NNE | -10.27% | $772.61M | +485.25% | 0.00% |
SYK | -9.84% | $145.54B | +21.31% | 0.84% |
TTEK | -9.76% | $11.34B | +29.73% | 2.11% |
BEST | -9.51% | $31.77M | +9.35% | 0.00% |
UFI | -9.38% | $112.71M | -1.28% | 0.00% |
TCTM | -9.32% | $2.68M | -74.53% | 0.00% |
ADBE | -9.24% | $185.84B | -28.09% | 0.00% |
BSX | -9.12% | $144.69B | +60.80% | 0.00% |
WM | -8.57% | $84.69B | +14.99% | 1.42% |
ORLY | -8.54% | $69.55B | +18.63% | 0.00% |
NTNX | -8.46% | $17.83B | +24.35% | 0.00% |
MESO | -8.25% | $1.94B | +869.19% | 0.00% |
TMUS | -8.23% | $250.38B | +30.84% | 1.30% |
Yahoo
As the U.S. equities market starts the new year with a continued slump, investors are closely monitoring opportunities that might emerge amidst broader market challenges. Penny stocks, often representing smaller or newer companies, remain an intriguing niche for those seeking growth potential beyond the well-trodden paths of large-cap investments. Despite their vintage name, these stocks can still offer surprising value and stability when backed by solid financial foundations.
Yahoo
Over the last 7 days, the United States market has dropped 2.6%, yet it has risen by 24% over the past year, with earnings expected to grow by 15% per annum in the coming years. In this context of fluctuating performance and anticipated growth, identifying high growth tech stocks involves looking at companies with innovative technologies and strong potential for future expansion.
Finnhub
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE...
Yahoo
AC Immune (ACIU) SA announced interim safety and tolerability data from the ABATE Phase 1b/2 trial of ACI-24.060 in individuals living with Down syndrome, DS. Targeting toxic forms of amyloid beta, ACI-24.060 is an active immunotherapy covering Abeta 1-15. The interim analysis was based on data from the first two cohorts of individuals with DS receiving low-dose and mid-dose ACI-24.060. DS subjects in the interim analysis have been treated for up to one year, with no serious adverse events relat
Yahoo
AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome ACI-24.060 was generally safe and well tolerated in individuals with Down syndrome with no serious adverse events related to the study drugNo cases of amyloid-related imaging abnormalities observed in this study populationBased upon these findings, AC Immune plans to open the high-dose cohort in ABATE in individuals with Down syndrome Lausanne, Switzerland, December 10, 2024 – AC Immune SA (NASDAQ: A
Finnhub
AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome · ACI-24.060 was generally safe and...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LMT | <0.01% | $115.40B | +5.94% | 2.62% |
UONEK | -0.01% | $40.77M | -76.16% | 0.00% |
BKNG | -0.01% | $161.02B | +37.87% | 0.71% |
SOLV | -0.02% | $12.56B | -9.14% | 0.00% |
CLMT | -0.03% | $1.56B | +11.48% | 0.00% |
HUSA | -0.04% | $22.51M | +5.52% | 0.00% |
CAMT | -0.04% | $4.49B | +29.59% | 0.00% |
FATBB | -0.05% | $80.77M | -20.10% | 11.55% |
TLPH | -0.06% | $10.56M | -36.02% | 0.00% |
LITB | -0.07% | $21.92M | -80.33% | 0.00% |
EG | 0.07% | $15.48B | -2.35% | 2.13% |
TSN | -0.08% | $19.56B | +4.57% | 3.52% |
CRM | -0.09% | $306.24B | +16.59% | 0.49% |
CMG | 0.10% | $79.52B | +25.62% | 0.00% |
NABL | -0.10% | $1.72B | -30.11% | 0.00% |
TXO | -0.12% | $760.58M | -0.59% | 12.60% |
BASE | -0.14% | $856.41M | -30.85% | 0.00% |
MRK | 0.16% | $254.73B | -15.05% | 3.10% |
FWONA | 0.19% | $20.41B | +44.79% | 0.00% |
SMCI | -0.20% | $18.22B | -0.08% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XRT | 35.14% | $469.81M | 0.35% |
XBI | 32.82% | $5.97B | 0.35% |
ARKG | 32.51% | $1.12B | 0.75% |
EFAA | 30.89% | $102.96M | 0% |
RSPA | 29.73% | $270.72M | 0% |
QVAL | 29.42% | $382.39M | 0.29% |
GNOM | 29.14% | $67.37M | 0.5% |
IBB | 28.95% | $6.29B | 0.45% |
ESPO | 28.64% | $280.79M | 0.56% |
RZV | 28.60% | $228.53M | 0.35% |
PBW | 28.57% | $297.37M | 0.65% |
ERTH | 28.27% | $145.58M | 0.67% |
PBE | 28.03% | $249.05M | 0.58% |
PAWZ | 27.81% | $60.38M | 0.5% |
QQA | 27.10% | $145.01M | 0% |
PFXF | 27.08% | $1.88B | 0.4% |
PBD | 27.06% | $77.54M | 0.75% |
FXD | 27.03% | $1.56B | 0.61% |
ACES | 27.02% | $119.30M | 0.55% |
SYLD | 27.01% | $1.27B | 0.59% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBMN | -0.04% | $484.25M | 0.18% |
TBIL | 0.07% | $4.83B | 0.15% |
UNG | 0.08% | $852.04M | 1.06% |
KRBN | -0.11% | $198.93M | 0.85% |
FLOT | -0.12% | $7.89B | 0.15% |
IVOL | -0.17% | $457.45M | 1.02% |
EWW | 0.24% | $1.13B | 0.5% |
BILZ | 0.38% | $616.99M | 0.14% |
GSY | 0.62% | $2.45B | 0.23% |
VRIG | 0.67% | $1.20B | 0.3% |
SHYD | 0.74% | $311.16M | 0.35% |
AGZD | -0.83% | $148.43M | 0.23% |
BLCN | 0.90% | $63.11M | 0.68% |
CLSE | 0.93% | $249.35M | 1.55% |
ICLO | 1.04% | $287.53M | 0.2% |
FLMX | 1.04% | $72.71M | 0.19% |
USCI | 1.36% | $201.05M | 1.07% |
MINT | -1.47% | $12.10B | 0.35% |
DUSB | -1.73% | $939.32M | 0.15% |
ULST | -1.93% | $549.72M | 0.2% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -14.37% | $195.31M | 0.85% |
UUP | -13.45% | $636.64M | 0.77% |
KCCA | -13.38% | $105.80M | 0.87% |
DBA | -12.00% | $817.28M | 0.93% |
USDU | -10.31% | $396.64M | 0.5% |
TBLL | -9.09% | $1.98B | 0.08% |
KMLM | -6.47% | $330.04M | 0.9% |
SGOV | -5.89% | $31.44B | 0.09% |
EQLS | -5.85% | $9.15M | 1% |
TAIL | -5.13% | $65.23M | 0.59% |
CTA | -4.02% | $553.08M | 0.76% |
IHI | -3.72% | $4.80B | 0.4% |
BOXX | -3.65% | $4.76B | 0.1949% |
BSSX | -2.75% | $63.43M | 0.18% |
XBIL | -2.29% | $643.80M | 0.15% |
SHV | -2.21% | $18.98B | 0.15% |
ULST | -1.93% | $549.72M | 0.2% |
DUSB | -1.73% | $939.32M | 0.15% |
MINT | -1.47% | $12.10B | 0.35% |
AGZD | -0.83% | $148.43M | 0.23% |